CCRA Seminar: UK Clinical Research: A Professional Awareness Update
The event is the tenth seminar the CCRA has held in the UK Clinical Research: A Professional Awareness Update series.
The CCRA has ran the series biannually since 2014 and in more recent years, has covered how the industry will be affected by Brexit. With an aim in informing and assisting to optimise clinical research regulations, procedures and support to maintain UK’s position as an ideal location to develop new drugs and medical devices.
The event aims to bring together key stakeholders from government departments, regulators, industry experts, the wider community of healthcare professionals and patients to deliver exclusive insights and a roadmap for continued success of the UK domestic research industry.
The seminar includes talks such as:
- Engagement of the Sector with Government post the decision to leave the EU Dr Ali Hansford, Head of Regulatory Strategy Policy, ABPI
- An Update from the MHRA Dr Martin O’Kane, Head of Clinical Trials Unit, MHRA
- Who’s Trial is it anyway? Dr David J Collier, Clinical Director, Clinical Trials Centre, QMUL and Paul Bowers Isaacson, Trials Patient and Co-Developer of TrialsConnect
- HRA Update on UK Compatibility Programme Alastair Nicholson, Senior Development Manager, HRA
- Successful Collaborations between Start-up/Emerging Pharmaceutical Companies and CROs – A Sponsor Perspective. Dr Alison McMorn, VP Clinical Development, AMO Pharma
- Updates since Implementation of GDPR Dr Lincoln Tsang, Partner, Arnold & Porter Kaye Scholer LLP
- Meeting round-up with final questions and discussion; including commentary from CCRA members on the importance of Trade Associations in the biopharma industry, for both contract and biopharma companies
Who are the CCRA
The CCRA is the government trade organisation (ATO) established to represent the CRO and allied industries. Members include clinical contract research organisations, contract manufacturers and companies that are specialist service providers to them and to the pharmaceutical and biotechnology industries.
The organisation was set up in order to address a variety of objectives which involve:
- Representing views and concerns of members to the government and EU legislative bodies such as regulatory agencies
- Support members by working with government agencies to promote services abroad
- Promote high standards of business and clinical practice through its code of practice
- Promote benefits of clinical contract research to pharmaceutical and biotech industries
- Safeguard health, welfare and interests of all participants in clinical trials
- Provide networking opportunities for members in UK and overseas
- Training courses specifically tailored towards member’s needs
- Provide an easily accessible communication platform for members, legislative agencies and potential volunteers via the CCRA website
If would like to contact the CCRA about this event, membership or other services they provide, please email firstname.lastname@example.org
For more information about Clinical Professionals and how we can help your business or career please email email@example.com.